News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC – International Urology Cancer Summit
Arnab Basu/uabmedicine.org
Jan 2, 2025, 19:20

Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC – International Urology Cancer Summit

International Urology Cancer Summit shared an article by Arnab Basu on LinkedIn:

“Advancing Precision Oncology in Metastatic RCC.

New findings highlight the potential of longitudinal ctDNA monitoring as a predictive biomarker for treatment response and progression-free survival in metastatic renal cell carcinoma (RCC).

This study demonstrates high concordance between ctDNA dynamics and clinical outcomes, paving the way for more personalized approaches to therapy and surveillance.

Discover how these insights could impact the future of RCC management.

Read the full study here.”

Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit

Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.

Authors: Arnab Basu, et al.

 Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit

Arnab Basu cancer ctDNA fight against cancer Global fight against cancer International Urology Cancer Summit metastatic renal cell carcinoma mRCC OncoDaily Oncology Precision Oncology
Special Coverage
Blog
May 5, 2025, 11:44
Jim Olson: I Was Raised by a Single Mom in rural Upper Michigan and Became an Pediatric Oncologist Who Discovered Cancer Therapies
Blog
May 5, 2025, 11:42
Corinne Faivre-Finn Honored with the ESTRO 2025 Breur Award
Blog
May 5, 2025, 11:19
Sumanta Pal: Can we come up with a score that rates the suitability of SWOG studies for LA countries?
Blog
May 5, 2025, 11:04
ESTRO25: What’s Happening on Day 3
Blog
May 5, 2025, 10:37
Amol Akhade: What’s your approach to adjuvant therapy?
Blog
May 5, 2025, 10:28
Narjust Florez: The Hope Summit is One of My Favorite Events Each Year
Science
May 5, 2025, 10:26
Jasmin Hundal: Can a WhatsApp-based remote exercise program improve the quality of life for older adults with cancer?
Blog
May 5, 2025, 10:12
Sanam Loghavi: Hagop Kantarjian on Quitting Bad Habits in CML at Think Tank 2025
Blog
May 5, 2025, 10:09
Yan Leyfman: Marginal Zone Lymphomas treatment landscapes, current challenges and what lies ahead
Blog
May 5, 2025, 10:09
Khalid Alsalman: Jeddah Oncology Center Presents Abstracts at ESTRO
Science
May 5, 2025, 10:03
Top Clinical Trials at ESTRO 2025: Organ Preservation and Quality of life after Total Neoadjuvant Therapy for LA Rectal Cancer
Blog
May 5, 2025, 09:52
Abhishek Shankar: It was an honour to participate in the International Scientific and Practical Conference